ImmunityBio, Inc. IBRX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$632.8M-921% | -$61.96M+7.9% | -$67.27M+27.3% | -$92.57M+28.6% | -$129.67M-119% | ||
| $4.38M+13.3% | $3.87M-2.2% | $3.95M+1.8% | $3.88M+1.3% | $3.83M-7.5% | ||
| $8.17M-6.6% | $8.75M-1.5% | $8.88M-8.0% | $9.65M+1.2% | $9.54M+5.5% | ||
| -$75.36M-7.1% | -$70.38M-2.1% | -$68.91M+13.6% | -$79.75M+7.2% | -$85.91M-0.9% | ||
| $1.78M+96.7% | $903K+21.9% | $741K-31.5% | $1.08M-3.6% | $1.12M-46.9% | ||
| -$31.65M— | —— | -$181.36M-1,024% | -$16.14M-491% | $4.13M— | ||
| $61K— | —— | —— | —— | $0— | ||
| $868K— | —— | —— | —— | $0— | ||
| $223.93M+308% | $54.89M-68.4% | $173.52M+0.4% | $172.81M+17,698% | -$982K-101% | ||
| $117.04M— | —— | -$76.81M— | —— | -$82.77M— | ||
| -$77.14M-8.2% | -$71.28M-2.3% | -$69.65M+13.8% | -$80.83M+7.1% | -$87.03M+0.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does ImmunityBio, Inc. generate?
- ImmunityBio, Inc. (IBRX) generated -$294.4M in operating cash flow over the trailing twelve months.
- What is ImmunityBio, Inc.'s free cash flow?
- After $4.5M of capital expenditures, ImmunityBio, Inc.'s free cash flow was -$298.9M over the trailing twelve months, up 20.7% year over year.
- Where does ImmunityBio, Inc.'s cash flow data come from?
- Every line is extracted from ImmunityBio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
